Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,122 | 252 | 25 | 27 | 37 |
| Receivables | N/A | 1,397 | N/A | N/A | N/A |
| Inventories | N/A | 2,501 | N/A | N/A | N/A |
| TOTAL | $2,122 | $4,193 | $25 | $28 | $38 |
| Non-Current Assets | |||||
| PPE Net | 5 | 3,262 | 5 | 5 | 6 |
| Investments And Advances | 61 | 43 | 61 | 61 | 61 |
| Other Non-Current Assets | 148 | 35 | 0 | 0 | 0 |
| TOTAL | $214 | $3,340 | $67 | $67 | $67 |
| Total Assets | $2,337 | $7,534 | $91 | $95 | $105 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 277 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 82 | 964 | 76 | 63 | 53 |
| Accrued Expenses | 2 | 133 | N/A | N/A | N/A |
| TOTAL | $2,334 | $5,079 | $76 | $63 | $53 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,044 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1 | 0 |
| TOTAL | $N/A | $3,044 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,334 | $8,123 | $76 | $63 | $53 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,784 | 314 | 314 | 314 | 314 |
| Common Shares | 38 | 45 | 4 | 4 | 4 |
| Retained earnings | -209 | -706 | -196 | -180 | -159 |
| Other shareholders' equity | -4 | 0 | -3 | -3 | -3 |
| TOTAL | $3 | $-589 | $15 | $31 | $51 |
| Total Liabilities And Equity | $2,337 | $7,534 | $91 | $95 | $105 |